Neuroscience News

A team of Stanford Bio-X scientists and engineers is creating a small wireless device that will improve studies of chronic pain. The scientists hope to use what they learn to develop better therapies for the condition, which costs the economy $600 billion

Yesterday the National Institutes of Health handed out the first $46 million in funding for their BRAIN initiative. Stanford neuroscientists Mark Schnitzer and Michael Lin got one of those awards worth almost $1 million to develop improved ways of recordi

It sounds like the dark plot of a vampire movie.

The genetic makeup of humans, fruit flies and roundworms is remarkably similar, which is why scientists have long favored using the latter two organisms to s

Stanford scientists have shown how the brain changes throughout life, and created a standard curve that can be used to assess whether patients are maturing and aging normally. This resource could help diagnose or monitor people with mental health conditio

A team of Bio-X scientists is developing a gel to help protect cells from the trauma of being injected into an injury site. The work could help speed cell-based therapies for spinal cord injuries and other types of damage.

An idea that started as a long shot – using light to control the activity of the brain – has earned Karl Deisseroth the Keio prize in medicine. The technique, called optogenetics, is now widely used at Stanford and worldwide to understand the brain's wiri

A Stanford Bio-X team found that the brain's wiring is more complex than expected – one set of neural wires can trigger different reactions, depending on how it fires. The work opens new questions for scientists trying to map the brain's connections.

A team of Stanford neurologists have found evidence that chronic pain triggers a series of molecular changes in the brain that may sap patients' motivation.

Optogenetically stimulating mice’s brains five days after stroke improved the animals’ motor control and brain biochemistry.

By Bruce Goldman

A national report on the value of interdisciplinary approaches in the sciences highlighted Stanford Bio-X as a model for success. Carla Shatz, the director of Stanford Bio-X, talks about the report's recommendations and the factors that have helped Bio-X

Instead of trying to address signs and symptoms seen in the end stage of disease, researchers are looking at what goes wrong much earlier in Alzheimer’s.

DARPA announces a new multi-million dollar effort to develop and test a new generation of therapeutic brain implants that will help service members, veterans and civilians recover from memory loss caused by brain trauma or disease.

Signaling activity along a single nerve tract deep within the brain predicts a living, wide-awake, freely moving animal’s tendency to socialize.